A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus
NCT03334058
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Pemphigus Vulgaris
Pemphigus Foliaceus
Interventions
DRUG:
ARGX-113
Sponsor
argenx